Beyond Diabetes

Every Intake. Earlier Insight. DTC helps capture chronic-risk signals at every intake, support care-gap discovery, and organize signals for provider-directed follow-up from ACO, VBC, and PCP networks.

Screen. Test. Treat.

Diabetes Testing Centers™ (DTC) began with diabetes-related testing and has evolved into a broader chronic-risk detection platform for modern primary care. Designed to integrate inside existing PCP clinics using as little as one dedicated room, no new space or infrastructure required — DTC helps primary care practices identify chronic-risk signals and connect them to focused, non-invasive assessment pathways . Our model is simple:

Screen using TriageIQ™.

Test with provider-selected assessments.

Treat through provider-directed care.

TriageIQ™ serves as the intake-level screener that helps capture what patients report but rarely volunteer — before it is missed, minimized, or left undocumented. When signals warrant a closer look, providers can evaluate them through whichever focused assessments, screenings, or testing pathways fit the patient and the practice — supporting care planning, monitoring, referrals, or follow-up decisions. The treating provider remains responsible for diagnosis, treatment, monitoring, referrals, and patient care. DTC does not replace the provider's judgment. It helps organize the path from early risk recognition to appropriate clinical action.

Most chronic diseases do not begin with a diagnosis. They often begin years earlier with subtle changes in how a patient feels, functions, moves, thinks, sleeps, sees, or tolerates daily life. Patients may explain these changes away as aging, stress, fatigue, pain, or "just getting older." Many never mention them during a routine visit unless they are asked in a structured way. That is the gap DTC is designed to close.

By capturing these early indicators at intake, documenting them while the patient is already present, and connecting them to appropriate next steps, practices can create a clearer path from early risk recognition to timely evaluation, monitoring, referral, or provider-directed care.

DTC is a family-owned healthcare company founded by former family practice owners who saw how often chronic risks were missed until preventable damage had begun. Combined with enterprise leadership in diabetes and diagnostics, that experience shaped a broader chronic-risk detection platform.

DTC adds structured screening and triage routing without a separate clinic or disruption to daily operations. Today, with access to a national network of more than 20,000 independent practices, DTC helps providers bring earlier detection and clearer care direction into the clinical workflow they already use.

The visit does not change — only the clinical insight it produces does.

Find Signals Sooner

Screen From Anywhere

In-Clinic or Remotely

Important chronic-risk signals often appear early — before they are clearly documented in the chart or raised during the visit. TriageIQ™ supports in-clinic or at-home intake, organizing patient-reported concerns through a proprietary, non-diagnostic framework before the visit, during intake, or through remote outreach. Providers get a consistent way to review potential risk indicators that might otherwise remain undocumented, fragmented, or delayed — and a clearer basis for determining whether further screening, assessment, testing, care-gap review, follow-up, or care-management consideration may be appropriate.

TriageIQ™ Adult serves as the broad front-end screener for the general adult population, organizing patient-reported chronic-risk signals through an age-appropriate framework designed for provider review.

TriageIQ™ Geriatric adds an age-focused layer for older adults, where chronic-risk patterns are often more complex, overlapping, and easily missed during routine intake. Its geriatric-risk framework supports provider review, follow-up planning, documentation, and care-gap awareness in the populations where early recognition matters most.

Both editions are non-diagnostic, patient-administered screeners. The specific screening architecture, question-to-risk mapping, scoring criteria, weighting, thresholds, and routing logic remain non-public and proprietary to Medrano & Associates LLC.

Find What Others Miss

Direction Before Diagnosis

what others miss

The case for earlier detection is not theoretical — it is measurable and clinically meaningful. By capturing what patients may already be experiencing in a structured way at intake, practices give providers a clearer, better-documented starting point for evaluating whether follow-up assessment, monitoring, referral, or care planning is appropriate.

Chronic damage accumulates long before symptoms become obvious, leaving providers to intervene later, when care is more reactive, costly, and complex. The challenge is that most primary care workflows are not built to consistently capture risk during that earlier window. Patients present with a chief complaint, and providers respond to what is reported.

DTC is designed to close that gap. Its broader health-risk detection model helps identify patient-reported risk signals earlier and organize them for provider review, so clinicians can direct patients toward appropriate evaluation, follow-up, clinical services, or care-management pathways — across fee-for-service, ACO/VBC, and Medicare Advantage workflows.

The practices that benefit most are not adding complexity. They are seeing their existing patients more completely — using a structured pathway to surface risk earlier, document it clearly, and move patients toward timely, provider-directed care.

Turn Intake to Insight

getting started

DTC organizes the path from screen to insight. Start with TriageIQ™ at intake or before, to identify patient-reported risk signals early and organize them for provider review. From there, your clinic can determine where focused screening, assessment, testing, referral, follow-up, or care-management consideration may be appropriate.

Getting Started Is Simple:

Start with TriageIQ™ at Intake
Identify potential risk signals early and consistently.
Review Patient-Reported Risk Signals
See where patients may warrant focused screening, testing, referral, follow-up, or care-management consideration.
Prioritize the Highest-Impact Pathways First
Some patients may need next-step review right away, while broader clinic patterns often become clearer within the first 30 to 90 days of consistent use.

Every Signal Matters

Screen Every Patient

Page updated

Report abuse